Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 107801-107850 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04080635
Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)
NA
Recruiting
100 participants
Started: Dec 14, 2018 · Completed: Dec 31, 2024
1 condition
3 sponsors
7 locations
NCT03673124
Ribociclib and Letrozole Treatment in Ovarian Cancer
PHASE2
Active, not recruiting
51 participants
Started: Dec 14, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
27 locations
NCT03773367
Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
PHASE2
Active, not recruiting
60 participants
Started: Dec 14, 2018 · Completed: Nov 30, 2026
1 condition
1 sponsor
4 locations
NCT03572764
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
PHASE1
Active, not recruiting
20 participants
Started: Dec 14, 2018 · Completed: Mar 25, 2027
1 condition
2 sponsors
3 locations
NCT03852004
Osteopathic Treatment on Motor Development of Hypotonic Infants.
NA
Recruiting
40 participants
Started: Dec 13, 2018 · Completed: Jan 13, 2026
1 condition
2 sponsors
2 locations
NCT03946930
Cognitive Decline in AD
N/A
Recruiting
500 participants
Started: Dec 13, 2018 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03752697
Metacognition in Neurological Injury
N/A
Recruiting
100 participants
Started: Dec 13, 2018 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT03427736
Anesthetics and Analgesics in Children
N/A
Recruiting
460 participants
Started: Dec 13, 2018 · Completed: Sep 9, 2026
2 conditions
2 sponsors
13 locations
NCT03789604
A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
479 participants
Started: Dec 13, 2018 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT03769155
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
PHASE1
Active, not recruiting
41 participants
Started: Dec 13, 2018 · Completed: Dec 15, 2032
3 conditions
5 sponsors
1 location
NCT04629586
The T1D Exchange Registry
N/A
Recruiting
50,000 participants
Started: Dec 13, 2018 · Completed: Dec 31, 2030
4 conditions
1 sponsor
1 location
NCT03601078
An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma
PHASE2
Active, not recruiting
248 participants
Started: Dec 13, 2018 · Completed: Oct 15, 2025
1 condition
1 sponsor
25 locations
NCT03771508
Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
N/A
Active, not recruiting
8,000 participants
Started: Dec 13, 2018 · Completed: Sep 30, 2025
6 conditions
1 sponsor
30 locations
NCT03797391
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
PHASE1/PHASE2
Recruiting
186 participants
Started: Dec 13, 2018 · Completed: Jan 15, 2026
3 conditions
2 sponsors
5 locations
NCT03783507
Foods Within a Meal and Food Liking Study
NA
Active, not recruiting
62 participants
Started: Dec 13, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03483038
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
PHASE2
Active, not recruiting
45 participants
Started: Dec 13, 2018 · Completed: Feb 28, 2026
1 condition
2 sponsors
4 locations
NCT05142800
Screening For BCRL In Targeted Therapy For Breast Cancer
N/A
Active, not recruiting
166 participants
Started: Dec 13, 2018 · Completed: Sep 30, 2026
11 conditions
2 sponsors
1 location
NCT03755804
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
PHASE2
Active, not recruiting
232 participants
Started: Dec 12, 2018 · Completed: Jul 1, 2028
1 condition
3 sponsors
8 locations
NCT03694756
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
NA
Recruiting
75 participants
Started: Dec 12, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03652545
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease
PHASE1
Active, not recruiting
33 participants
Started: Dec 12, 2018 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
PHASE1
Recruiting
59 participants
Started: Dec 12, 2018 · Completed: Sep 30, 2041
13 conditions
3 sponsors
1 location
NCT05390229
Screening Contrast-enhanced Mammography
N/A
Recruiting
300 participants
Started: Dec 12, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05049330
Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool
N/A
Recruiting
22,222 participants
Started: Dec 12, 2018 · Completed: Sep 1, 2026
1 condition
1 sponsor
18 locations
NCT03984318
Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NA
Active, not recruiting
1,240 participants
Started: Dec 12, 2018 · Completed: Dec 11, 2028
1 condition
1 sponsor
5 locations
NCT03861884
Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)
N/A
Recruiting
125 participants
Started: Dec 12, 2018 · Completed: Mar 31, 2025
1 condition
1 sponsor
2 locations
NCT03694249
Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
PHASE2
Active, not recruiting
30 participants
Started: Dec 12, 2018 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT03742895
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
PHASE2
Active, not recruiting
390 participants
Started: Dec 12, 2018 · Completed: Jun 30, 2026
1 condition
2 sponsors
130 locations
NCT03804853
Rehabilitation Following Reverse Total Shoulder Arthroplasty
NA
Recruiting
74 participants
Started: Dec 12, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04616508
Online Motor Control in People With Parkinson's Disease
NA
Recruiting
100 participants
Started: Dec 12, 2018 · Completed: Dec 12, 2026
2 conditions
2 sponsors
1 location
NCT03642002
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
NA
Recruiting
178 participants
Started: Dec 12, 2018 · Completed: Dec 31, 2028
3 conditions
1 sponsor
3 locations
NCT03762850
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
PHASE3
Active, not recruiting
406 participants
Started: Dec 11, 2018 · Completed: Jul 31, 2026
1 condition
1 sponsor
162 locations
NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
PHASE2
Active, not recruiting
40 participants
Started: Dec 11, 2018 · Completed: Dec 31, 2030
13 conditions
1 sponsor
35 locations
NCT03585114
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
PHASE2
Active, not recruiting
11 participants
Started: Dec 11, 2018 · Completed: Dec 31, 2022
1 condition
1 sponsor
1 location
NCT03517579
Personalized Treatment in Thyroid Disorders
NA
Recruiting
10 participants
Started: Dec 11, 2018 · Completed: Dec 15, 2027
2 conditions
1 sponsor
1 location
NCT03639025
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
N/A
Active, not recruiting
458 participants
Started: Dec 10, 2018 · Completed: Nov 30, 2029
1 condition
1 sponsor
18 locations
NCT03609216
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
PHASE2
Recruiting
271 participants
Started: Dec 10, 2018 · Completed: Feb 1, 2029
3 conditions
2 sponsors
423 locations
NCT03767075
A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)
PHASE2
Recruiting
1,000 participants
Started: Dec 10, 2018 · Completed: Nov 30, 2026
1 condition
5 sponsors
8 locations
NCT04092855
Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery
N/A
Recruiting
112 participants
Started: Dec 10, 2018 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT03531450
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
NA
Recruiting
29 participants
Started: Dec 7, 2018 · Completed: Feb 25, 2027
1 condition
1 sponsor
1 location
NCT02997878
Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Dec 7, 2018 · Completed: Oct 1, 2025
2 conditions
2 sponsors
1 location
NCT03583684
Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children with Autism
NA
Recruiting
36 participants
Started: Dec 7, 2018 · Completed: Nov 30, 2026
2 conditions
2 sponsors
1 location
NCT03513731
Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint
NA
Recruiting
40 participants
Started: Dec 7, 2018 · Completed: Apr 30, 2026
1 condition
2 sponsors
2 locations
NCT03996850
SPECT/CT for the Characterization of Renal Masses
N/A
Recruiting
100 participants
Started: Dec 7, 2018 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03701334
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
PHASE3
Active, not recruiting
5,101 participants
Started: Dec 7, 2018 · Completed: May 29, 2026
1 condition
2 sponsors
387 locations
NCT03579316
Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE2
Active, not recruiting
96 participants
Started: Dec 7, 2018 · Completed: Dec 31, 2025
3 conditions
2 sponsors
2 locations
NCT03800134
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
PHASE3
Active, not recruiting
825 participants
Started: Dec 6, 2018 · Completed: Sep 11, 2028
1 condition
1 sponsor
231 locations
NCT03815123
Register Kardialer Computertomographie
N/A
Recruiting
10,000 participants
Started: Dec 6, 2018 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT03766126
Lentivirally Redirected CD123 Autologous T Cells in AML
PHASE1
Active, not recruiting
22 participants
Started: Dec 6, 2018 · Completed: Dec 3, 2033
3 conditions
1 sponsor
1 location
NCT04621201
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
N/A
Recruiting
120 participants
Started: Dec 6, 2018 · Completed: Dec 6, 2026
1 condition
2 sponsors
10 locations
NCT03549715
NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma
PHASE1/PHASE2
Active, not recruiting
121 participants
Started: Dec 6, 2018 · Completed: Sep 30, 2025
1 condition
1 sponsor
15 locations
Previous
1
More pages
2154
2155
2156
2157
2158
2159
2160
More pages
2369
Next